WallStreetZenWallStreetZen

NASDAQ: MRVI
Maravai Lifesciences Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRVI

Based on 8 analysts offering 12 month price targets for Maravai Lifesciences Holdings Inc.
Min Forecast
$13.00-2.48%
Avg Forecast
$19.88+49.1%
Max Forecast
$27.00+102.55%

Should I buy or sell MRVI stock?

Based on 8 analysts offering ratings for Maravai Lifesciences Holdings Inc.
Buy
Strong Buy
3 analysts 37.5%
Buy
2 analysts 25%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MRVI stock forecasts and price targets.

MRVI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Top 7%
94
HoldDowngrades$14.00+5.03%2023-05-23
Goldman Sachs
Bottom 3%
3
HoldMaintains$13.00-2.48%2023-05-10
Morgan Stanley
Bottom 7%
7
Strong BuyMaintains$27.00+102.55%2023-05-10
RBC Capital
Bottom 18%
18
BuyMaintains$20.00+50.04%2023-05-09
Deutsche Bank
Bottom 12%
12
Strong BuyMaintains$23.00+72.54%2023-05-09
Baird
Top 4%
97
BuyMaintains$22.00+65.04%2023-02-23
KeyBanc
Top 12%
89
Strong BuyMaintains$24.00+80.05%2023-02-23
UBS
Top 14%
87
HoldDowngrades$16.00+20.03%2023-01-05

1 of 1

Forecast return on equity

Is MRVI forecast to generate an efficient return?
Company
58.23%
Industry
29.39%
Market
89.83%
MRVI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MRVI forecast to generate an efficient return on assets?
Company
13.12%
Industry
11.66%
MRVI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MRVI earnings growth forecast

How is MRVI forecast to perform vs Biotechnology companies and vs the US market?
Company
-8.93%
Industry
10.89%
Market
34.42%
MRVI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MRVI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MRVI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MRVI revenue growth forecast

How is MRVI forecast to perform vs Biotechnology companies and vs the US market?
Company
-6.63%
Industry
63.97%
Market
8.87%
MRVI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRVI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRVI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRVI$13.33$19.88+49.10%Buy
DNA$1.62$1.25-22.84%Strong Sell
PTCT$44.12$52.67+19.37%Buy
IMGN$14.37$13.33-7.22%Buy
AXSM$74.12$101.38+36.77%Buy
View Top Biotech Stocks

Maravai Lifesciences Holdings Stock Forecast FAQ

Is Maravai Lifesciences Holdings Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: MRVI) stock is to Buy MRVI stock.

Out of 8 analysts, 3 (37.5%) are recommending MRVI as a Strong Buy, 2 (25%) are recommending MRVI as a Buy, 3 (37.5%) are recommending MRVI as a Hold, 0 (0%) are recommending MRVI as a Sell, and 0 (0%) are recommending MRVI as a Strong Sell.

If you're new to stock investing, here's how to buy Maravai Lifesciences Holdings stock.

What is MRVI's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: MRVI) forecast ROE is 58.23%, which is considered strong.

What is MRVI's Price Target?

According to 8 Wall Street analysts that have issued a 1 year MRVI price target, the average MRVI price target is $19.88, with the highest MRVI stock price forecast at $27.00 and the lowest MRVI stock price forecast at $13.00.

On average, Wall Street analysts predict that Maravai Lifesciences Holdings's share price could reach $19.88 by May 23, 2024. The average Maravai Lifesciences Holdings stock price prediction forecasts a potential upside of 49.1% from the current MRVI share price of $13.33.

What is MRVI's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: MRVI) forecast ROA is 13.12%, which is higher than the forecast US Biotechnology industry average of 11.66%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.